These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9421009)
21. Transfusion premedications: a growing practice not based on evidence. Tobian AA; King KE; Ness PM Transfusion; 2007 Jun; 47(6):1089-96. PubMed ID: 17524101 [No Abstract] [Full Text] [Related]
22. [Elution technics for the detection of antibodies in hemolytic disease of the newborn]. Gota F; Dallavalle FM Arch Sci Med (Torino); 1980; 137(4):567-9. PubMed ID: 7018457 [No Abstract] [Full Text] [Related]
28. Haemolytic disease of the newborn caused by anti-MUT (MNS 35). van den Bos AG; Steiner K Vox Sang; 2004 Oct; 87(3):208-9. PubMed ID: 15569075 [No Abstract] [Full Text] [Related]
29. Transfusion related acute lung injury: a pediatric perspective. Sanchez R; Toy P Pediatr Blood Cancer; 2005 Sep; 45(3):248-55. PubMed ID: 15852432 [TBL] [Abstract][Full Text] [Related]
30. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Stussi G; Halter J; Schanz U; Seebach JD Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028 [TBL] [Abstract][Full Text] [Related]
31. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies]. Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054 [TBL] [Abstract][Full Text] [Related]
33. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B. Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W; Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669 [TBL] [Abstract][Full Text] [Related]
34. Do we need to be more concerned about weak D antigens? Garratty G Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202 [No Abstract] [Full Text] [Related]
35. Hyperhemolysis syndrome: a relative contraindication for transfusion. Lu RP; Clark P; Mintz PD J Hosp Med; 2008 Jan; 3(1):78-80. PubMed ID: 18257051 [No Abstract] [Full Text] [Related]
36. Immunological aspects of blood transfusions. Brand A Transpl Immunol; 2002 Aug; 10(2-3):183-90. PubMed ID: 12216948 [TBL] [Abstract][Full Text] [Related]
37. Allosensitization in patients receiving multiple blood transfusions. Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705 [TBL] [Abstract][Full Text] [Related]
38. Post-transfusion detection of RBC alloimmunization: Timing is everything. Stack G Transfusion; 2021 Aug; 61(8):2219-2222. PubMed ID: 34289127 [No Abstract] [Full Text] [Related]
39. [The transfusion aspects of allogeneic bone marrow transplantation]. Fregatova LM; Volkova OIa; Shavva SA; Platonova GG; Afanas'ev BV Ter Arkh; 1998; 70(7):67-9. PubMed ID: 9742642 [TBL] [Abstract][Full Text] [Related]
40. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Rowley SD; Liang PS; Ulz L Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]